A detailed history of Personal Capital Advisors Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Personal Capital Advisors Corp holds 10,491 shares of BMY stock, worth $558,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,491
Previous 10,675 1.72%
Holding current value
$558,016
Previous $759,000 0.66%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $12,600 - $14,920
-184 Reduced 1.72%
10,491 $754,000
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $89 - $52,712
-686 Reduced 6.04%
10,675 $759,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $33,550 - $36,950
-462 Reduced 3.91%
11,361 $875,000
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $77,587 - $93,034
-1,262 Reduced 9.64%
11,823 $863,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $111,014 - $129,416
-2,070 Reduced 13.66%
13,085 $815,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $6.87 Million - $8.05 Million
-116,142 Reduced 88.46%
15,155 $897,000
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $891,999 - $971,387
14,408 Added 12.33%
131,297 $8.77 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $1.16 Million - $1.3 Million
19,543 Added 20.08%
116,889 $7.38 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $865,811 - $981,122
14,995 Added 18.21%
97,346 $6.04 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $312,189 - $345,947
5,436 Added 7.07%
82,351 $4.97 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $223,007 - $260,718
4,068 Added 5.58%
76,915 $4.52 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $168,292 - $244,568
3,627 Added 5.24%
72,847 $4.07 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $688,152 - $897,632
13,984 Added 25.32%
69,220 $4.44 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $320,176 - $379,615
7,486 Added 15.68%
55,236 $2.8 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $508,623 - $562,426
11,399 Added 31.36%
47,750 $2.17 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $411,404 - $490,548
9,118 Added 33.48%
36,351 $1.73 Million
Q4 2018

Jan 16, 2019

BUY
$48.76 - $63.23 $225,953 - $293,007
4,634 Added 20.51%
27,233 $1.42 Million
Q3 2018

Oct 09, 2018

BUY
$55.19 - $62.25 $377,609 - $425,914
6,842 Added 43.42%
22,599 $1.4 Million
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $485,947 - $605,678
9,617 Added 156.63%
15,757 $872,000
Q1 2018

May 09, 2018

BUY
$59.92 - $68.98 $367,908 - $423,537
6,140 New
6,140 $388,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Personal Capital Advisors Corp Portfolio

Follow Personal Capital Advisors Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.